Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: Correlations with behavior and oxidative stress

Neurochemistry International

Volumn 55, Issue 8, 2009, Pages 806-814

  Strazielle, Catherine ^a,b   Jazi, Rozat ^a,b   Verdier, Yann ^b,c   Qian, Sue ^d   Lalonde, Robert ^e,f  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Brain Plasticity Unit   (France)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITÉ DE ROUEN   (France)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alzheimer's disease; Cytochrome c oxidative; Neuronal metabolism; Oxidative DNA damage; Presenilin1

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AMYLOID BETA PROTEIN[1-42]; CYTOCHROME C OXIDASE; PRESENILIN 1; PROSTAGLANDIN SYNTHASE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; FOREBRAIN; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOMOTOR RETARDATION; THALAMUS MIDLINE NUCLEUS;

EID: 70350012316     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.08.005     Document Type: Article

References (104)

1. Aksenov M.Y., Tucker H.M., Nair P., Aksenova M.V., Butterfield D.A., Estus S., and Markesbery W.R. The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. Neurochem. Res. 24 (1999) 767-774
2. Aliev G., Smith M.A., Seyidova D., Neal M.L., Lamb B.T., Nunomura A., Gasimov E.K., Vinters H.V., Perry G., LaManna J.C., and Friedland R.P. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 12 (2002) 21-35
3. Barrow P.A., Empson R.M., Gladwell S.J., Anderson C.M., Killick R., Yu X., Jefferys J.G.R., and Duff K. Functional phenotype in transgenic mice expressing human mutant presenilin-1. Neurobiol. Dis. 7 (2000) 119-126
4. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
5. Begley J.G., Duan W., Chan S., Duff K., and Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72 (1999) 1030-1039
6. Bell K.F.S., and Cuello A.C. Altered synaptic function in Alzheimer's disease. Eur. J. Pharmacol. 545 (2006) 11-21
7. Bell K.F.S., Bennett D.A., and Cuello A.C. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J. Neurosci. 27 (2007) 10810-10817
8. Bojarski L., Herms J., and Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 52 (2008) 621-633
9. Borchelt D.R., Van Lare J., Lee M.K., Gonzalez V., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 (1997) 939-945
10. Brock B., Basha R., DiPalma K., Anderson A., Harry G.J., Rice D.C., Maloney B., Lahiri D.K., and Zawia N.H. Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis. J. Alzheimers Dis. 13 (2008) 71-80
11. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.-H., Haass C., Staufenbiel M., Konnerth A., and Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 231 (2008) 1686-1689
12. Butcher L.L. Cholinergic neurons and networks. In: Paxinos G. (Ed). The Rat Nervous System. 2nd ed. (1995), Academic Press, New York 1003-1015
13. Canevari L., Clark J.B., and Bates T.E. β-amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457 (1999) 131-134
14. Casley C.S., Canevari L., Land J.M., Clark J.B., and Sharpe M.A. β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80 (2002) 91-100
15. Cassarino D.S., and Bennett J.P. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29 (1999) 1-25
16. Chandrasekaran K., Hatanpää K., Brady D.R., Stoll J., and Rapoport S.I. Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mDNA in the hippocampus and entorhinal cortex. Brain Res. 796 (1998) 13-19
17. Chui D.-H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K., Takahashi K., Gallyas F., and Tabira T. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5 (1995) 560-564
18. Citron M., Westway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George-Hyslop P., and Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3 (1997) 67-72
19. Contestabile A., Fila T., Bartesaghi R., Contestabile A., and Ciani E. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. J. Neurochem. 97 (2006) 515-526
20. Cottrell D.A., Blakely E.L., Kohnson M.A., Ince P.G., and Turnbull D.M. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57 (2001) 260-264
21. Czech C., Lesort M., Tremp G., Terro F., Blanchard V., Schombert B., Carpentier N., Dreisler S., Bonici B., Takashima A., Moussaoui S., Hugon J., and Pradier L. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience 87 (1998) 325-336
22. Damjanac M., Rioux-Bilan A., Barrier L., Pontcharraud R., Anne C., Hugon J., and Page G. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Res. 1128 (2007) 40-49
23. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennet D.A., Cochran E.J., Kordower J.H., and Mufson E.J. Upregulation of cholinetransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51 (2002) 145-155
24. Devi L., Prabhu B.M., Galati D.F., Avadhani N.G., and Anandatheerthavarada H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26 (2006) 9057-9068
25. Dickerson B.C., Salat D.H., Greve D.N., Chua E.F., Rand-Giovannetti E., Rentz D.M., Bertram L., Mullin K., Tanzi R.E., Blacker D., Albert M.S., and Sperling R.A. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65 (2005) 404-411
26. Dowjat W.K., Wisniewski H., and Wisniewski T. Alzheimer's disease presinilin-1 expression modulates the assembly of neurofilaments. Neuroscience 103 (2001) 1-8
27. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-Tur J., Hutton J., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., and Younkin S. Increased β-amyloid42(43) in brains of mice expressing mutant presenilin 1. Nature 383 (1996) 710-713
28. de la Monte S.M., Neely T.R., Cannon J., and Wands J.R. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell. Mol. Life Sci. 57 (2000) 1471-1481
29. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, New York
30. Fukui H., Diaz F., Garcia S., and Moraes C.T. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14163-14168
31. Gerfen C.R. Basal ganglia. In: Paxinos G. (Ed). The Rat nervous System. 3d ed. (2004), Elsevier, New York 455-508
32. Gonzalez-Lima F., and Jones D. Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry. Brain Res. 660 (1994) 34-39
33. Graybiel A.M. The basal ganglia. Trends Neurosci. 18 (1995) 60-62
34. Grilli M., Diodato E., Lozza G., Brusa R., Casarini M., Uberti D., Rozmahel R., Westaway D., St. George-Hyslop P., Memo M., and Ongini E. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12822-12827
35. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., and Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5 (2005) 101-106
36. Hamblet N.S., Ragland B., Ali M., Conyers B., and Castora F.J. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 27 (2006) 398-408
37. Hellström-Lindahl E., Viitanen M., and Maruttle A. Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease. Neurochem. Int. 55 (2009) 243-252
38. Herholtz K., Weisenbach S., Zündorf G., Lenz O., Schröder H., Bauer B., Kalbe E., and Heiss W.D. In vivo study of acetylcholinesterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. NeuroImage 21 (2004) 136-143
39. Hevner R.F., and Wong-Riley M.T.T. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13 (1993) 1805-1819
40. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlack S.L., Harris P.L.R., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
41. Hu Q., Jin L.-W., Starbuck M.Y., and Martin G.M. Broadly altered expression of the mRNA isoforms of FE65, a facilitator of Beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. J. Neurosci. 60 (2000) 73-86
42. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-595
43. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., and Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1998) 1585-1593
44. Iverfeldt K., Walaas S.I., and Greengard P. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4146-4150
45. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., and Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase. Hum. Mol. Genet. 13 (2004) 159-170
46. Janus C., D'Amelio S., Amitay O., Chishti M.A., Strome R., Fraser P., Carlson G.A., Roder J.C., St. George-Hyslop P., and Westaway D. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol. Aging 21 (2000) 541-549
47. Jazi R., Lalonde R., Qian S., and Strazielle C. Regional brain evaluation of acetylcholinesterase activity in PS1/A246E transgenic mice. Neurosci. Res. 63 (2009) 106-114
48. Kang D.E., Soriano S., Frosch M.P., Collins T., Naruse S., Sisodia S.S., Leibowitz G., Levine F., and Koo E.H. Presenilin 1 facilitates the constitutive turnover of β-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the β-catenin-signalling pathway. J. Neurosci. 19 (1999) 4229-4237
49. Keil U., Bonert A., Marques C.A., Sherping I., Weyermann J., Strosznajder J.B., Müller-Spahn F., Haass C., Czech C., Pradier L., Müller W.E., and Eckert A. Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 279 (2004) 50310-50320
50. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.-J., Wilson J.M., DiStefano L.M., and Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59 (1992) 776-779
51. Kish S.J., Mastrogiacomo F., Gutman M., Furukawa Y., Taanman J.-W., Dozic S., Pandolfo M., Lamarche J., DiStefano L., and Chang L.-J. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?. J. Neurochem. 72 (1999) 700-707
52. Lalonde R., Jazi R., and Strazielle C. Neurobehavioral characteristics of presenilin transgenic mice. In: Sun M.-K. (Ed). Cognitive Sciences vol. 1 (2006), Nova Science Publishers, New York 169-204
53. Lalonde R., Qian S., and Strazielle C. Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav. Brain Res. 138 (2003) 71-79
54. Lemere C.A., Lopera F., Kosik K.S., Lendon C.L., Ossa J., Saido T.C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J.C.L., Anthony D.C., Koo E.H., Goate A.M., Selkoe D.J., and Arango J.C.V. The E280A presenilin 1 Alzheimer mutation produced increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2 (1996) 1146-1150
55. Leutner S., Czech C., Schindowski K., Touchet N., Eckert A., and Müller W.E. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations. Neurosci. Lett. 292 (2000) 87-90
56. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., and Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11 (2002) 133-145
57. Lyness S.A., Zarow C., and Chui H.C. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer's disease: a meta-analysis. Neurobiol. Aging 24 (2003) 1-23
58. Manczak M., Park B.S., Jung Y., and Reddy P.H. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease. Neuromol. Med. 5 (2004) 147-163
59. Martorana A., Stefani A., Palmieri M.G., Esposito Z., Bernardi G., Sancesario G., and Pierantozzi M. L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J. Neural Transm. 115 (2008) 1313-1319
60. Maurer I., Zierz S., and Möller H.-J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurol. Aging 21 (2000) 455-462
61. Migliore L., Fontana I., Trippi F., Colognato R., Coppedè F., Tognoni G., Nucciarone B., and Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 26 (2005) 567-573
62. Miravalle L., Calero M., Takuo M., Roher A.E., Ghetti B., and Vidal R. Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques. Biochemistry 44 (2005) 10810-10821
63. Nagy Z., Esiri M.M., LeGris M., and Matthews P.M. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol. 97 (1999) 346-354
64. Niwa K., Carlson G.A., and Iadecola C. Exogenous Abeta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J. Cereb. Blood Flow Metab. 20 (2000) 1659-1668
65. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwwod C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
66. Parker W.D., and Davis R.E. Primary mitochondrial DNA defects as a causative event in Alzheimer's disease. In: Beal M.F., Howell N., and Bodis-Wollner I. (Eds). Mitochondria and Free Radicals in Neurodegenerative Diseases (1997), Wiley-Liss, New York 319-333
67. Parker W.D., Filley C.M., and Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40 (1990) 1302-1303
68. Parker W.D., and Parks J.K. Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45 (1995) 482-486
69. Parks J.K., Smith T.S., Trimmer P.A., Bennett J.P., and Parker W.D. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 76 (2001) 1050-1056
70. Pettegrew J.W., Panchalingam K., Klunk W.E., McClure R.J., and Muenz L.R. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol. Aging 15 (1994) 117-132
71. Piccini A., Zanusso G., Borghi R., Noviello C., Monaco S., Russo R., Damonte G., Amirotti A., Gelati M., Giordano R., Zambenedetti P., Russo C., Ghetti B., and Tabaton M. Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch. Neurol. 64 (2007) 738-745
72. Price J.L. Thalamus. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, New York 629-648
73. Qian S., Jiang P., Guan X.-M., Singh G., Trumbauer M.E., Yu H., Chen H.Y., Van der Ploeg L.H.T., and Zheng H. Mutant human presenilin-1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 production. Neuron 20 (1998) 611-617
74. Qiu X., Chen Y., and Zhou M. Two point mutations in mitochondrial DNA of cytochrome oxidase coexist with normal mtDNA in a patient with Alzheimer's disease. Brain Res. 893 (2001) 261-263
75. Rapoport S.I. Functional brain imaging in the resting state and during activation in Alzheimer's disease: implications for disease mechanisms involving oxidative phosphorylation. Ann. N.Y. Acad. Sci. 893 (1999) 138-153
76. Reader T.A., and Strazielle C. Quantitative autoradiography of monoamine uptake sites and receptors in rat and mouse brain. In: Boulton A.A., Baker G.B., and Bateson A.N. (Eds). Neuromethods, Cell Neurobiology Techniques vol. 33 (1999), Humana Press, Totowa 1-51
77. Reddy P.H., McWeeney S., Park B.S., Manczak M., Gutala R.V., Partovi D., Jung Y., Yau V., Searles R., Mori M., and Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13 (2004) 1225-1240
78. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., and Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334 (1996) 752-758
79. Reiman E.M., Lane R.D., Ahern G.L., Schwartz G.E., Davidson R.J., Friston K.J., Yun L.S., and Chen K. Neuroanatomical correlates of externally and internally generated human emotion. Am. J. Psychiatry 154 (1997) 918-925
80. Reisine T.D., Soubrie P., Artaud F., and Glowinski J. Involvement of lateral habenula-dorsal raphe neurons in the differential regulation of striatal and nigral serotoninergic transmission in cats. J. Neurosci. 2 (1982) 1062-1071
81. Rui Y., Tiwari P., Xie Z., and Zheng J.Q. Acute impairment of mitochondrial trafficking by β-amyloid peptides in hippocampal neurons. J. Neurosci. 26 (2006) 10480-10487
82. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
83. Simonian N.A., and Hyman B.T. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53 (1994) 508-512
84. Sisodia S.S., Kim S.H., and Thinakaran G. Function and dysfunction of the presenilins. Am. J. Hum. Genet. 65 (1999) 7-12
85. Shinotoh H., Namba H., Fukushi K., Nagatsuka S., Tanaka N., Aotsuka A., Ota T., Tanada S., and Irie T. Progressive loss of cortical acetylcholinesterase activity in association with decline in Alzheimer's disease: a positron emission tomography study. Ann. Neurol. 48 (2000) 194-200
86. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., and Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6037-6042
87. Steckler T., Inglis W., Winn P., and Sahgal A. The pedunculopontine tegmental nucleus: a role in cognitive processes?. Brain Res. Rev. 19 (1994) 298-318
88. Steininger T.L., Rye D.B., and Wainer B.H. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat, retrograde tracing studies. J. Comp. Neurol. 321 (1992) 515-543
89. Strazielle C., Dumont M., Fukuchi K., and Lalonde R. Transgenic mice expressing the human C99 terminal fragment of β-APP: effects on cytochrome oxidase activity in skeletal muscle and brain. J. Chem. Neuroanat. 27 (2004) 237-246
90. Strazielle C., Krémarik P., Ghersi-Egea J.-F., and Lalonde R. Regional brain variations of cytochrome oxidase activity and motor coordination in Lurcher mutant mice. Exp. Brain Res. 121 (1998) 35-45
91. Strazielle C., Sturchler-Pierrat C., Staufenbiel M., and Lalonde R. Regional brain cytochrome oxidase activity on β-amyloid precursor protein transgenic mice with the Swedish mutation. Neuroscience 118 (2003) 1151-1163
92. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P., Davis R.E., and Parker W.D. Cybrids in Alzheimer's disease: a cellular model of disease?. Neurology 4 (1997) 918-925
93. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
94. Valla J., Berndt J.D., and Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J. Neurosci. 21 (2001) 4923-4930
95. Wang J., Xiong S., Xie C., Markesbery W.R., and Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93 (2005) 953-962
96. Weinshenker D. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr. Alzheimer Res. 5 (2008) 342-345
97. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
98. Winn P., Brown V.J., and Inglis W.L. On the relationships between the striatum and the pedunculopontine nucleus. Crit. Rev. Neurobiol. 11 (1997) 241-261
99. Wong-Riley M.T.T. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171 (1979) 11-28
100. Wong-Riley M.T.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12 (1989) 94-101
101. Wong-Riley M., Antuono P., Ho K.-C., Egan R., Hevner R., Liebl W., Huang Z., Rachel R., and Jones J. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res. 37 (1997) 3593-3608
102. Yukioka F., Matsuzaki S., Kawamoto K., Koyama Y., Hitomi J., Katayama T., and Tohyama M. Presenilin-1 mutation activates the signaling pathway of caspase-4 in endoplasmic reticulum stress-induced apoptosis. Neurochem. Int. 53 (2008) 263-269
103. Zhang C., and Wong-Riley M.T.T. Expression and regulation of NMDA receptor subunit R1 and neuronal nitric oxide synthase in cortical neuronal cultures: correlation with cytochrome oxidase. J. Neurocytol. 28 (1999) 525-539
104. Zhu X., Perry G., Moreira P.I., Aliev G., Cash A.D., Hirai K., and Smith M.A. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J. Alzheimer's Dis. 9 (2006) 147-153